A nanomaterial path forward for COVID-19 vaccine development

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines. Nanoengineers detail the current approaches to COVID-19 vaccine development, and highlight how nanotechnology has enabled these advances, in a review article.